Credit Suisse Ag Fortress Biotech, Inc. Transaction History

Credit Suisse Ag

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$3.16 - $4.89 $58,962 - $91,242	-18,659 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$2.2 - $4.45 $41,049 - $83,032	18,659 New	18,659 $59,000
Q2 2020 Aug 12, 2020	SELL	$1.83 - $3.16 $309,582 - $534,580	-169,171 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$1.14 - $2.96 $64,145 - $166,553	56,268 Added 49.84%	169,171 $320,000
Q4 2019 Feb 12, 2020	BUY	$1.25 - $2.57 $141,128 - $290,160	112,903 New	112,903 $290,000

Q2 2018 Aug 14, 2018	SELL	$2.92 - $5.1 $47,187 - $82,416	-16,160 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$3.42 - $5.35 $55,267 - $86,456	16,160 New	16,160 $74,000
Q4 2017 Feb 14, 2018	SELL	$3.26 - $4.84 $73,392 - $108,962	-22,513 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$3.83 - $4.89 $86,224 - $110,088	22,513	22,513 $99,000

1.01M

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $189M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.